BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 107515)

  • 1. [Epidemiological and clinical aspects of drug-resistant tubercle bacilli in children treated in the years 1961--1976].
    Robakiewicz M; Paszkowska A; Szczukowa W
    Pneumonol Pol; 1979 Feb; 47(2):107-16. PubMed ID: 107515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J; Chiba Y; Yanagisawa K
    Kekkaku; 1975 Feb; 50(2):55-62. PubMed ID: 815707
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on infection by drug-resistant tubercle bacilli. 2. Primary drug resistance in children].
    Osato T; Kihara K; Iwasaki T; Shimao T; Fukushima K
    Kekkaku; 1968 Oct; 43(10):431-6. PubMed ID: 4974634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug resistance in patients with pulmonary tuberculosis.
    Cheung OT
    Can Med Assoc J; 1975 Nov; 113(9):848-9. PubMed ID: 810238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of drug resistance in Mycobacterium tuberculosis and its clinical significance for children and adolescents].
    Rushchak VA; Kostromina VP; Klimenko MT
    Probl Tuberk; 1971; 49(8):88-90. PubMed ID: 5005006
    [No Abstract]   [Full Text] [Related]  

  • 10. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriological and clinical aspects of the restoration of drug sensitivity of formerly resistant Mycobacterium cultures].
    Rudoĭ NM; Bochkov EN
    Probl Tuberk; 1973; 51(10):24-6. PubMed ID: 4206103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P
    Arch Monaldi; 1972; 27(4):403-17. PubMed ID: 4217597
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M
    Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA
    Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
    [No Abstract]   [Full Text] [Related]  

  • 17. A 10 year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance.
    Lavy A; Mates A
    Isr J Med Sci; 1994 Nov; 30(11):805-10. PubMed ID: 7982768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.